1. Home
  2. Conference
  3. TSCA Developments 2020

Programme

  1. Welcome and introduction

    Moderator:

  2. Session one: Regulatory updates

  3. Keynote: TSCA Updates from the EPA

  4. TSCA chemical data reporting (CDR) 2020: Something old, something new

    • Update on the current reporting window
    • Update on the small business definition

  5. TSCA fees

    • Upcoming rulemaking on fee exemptions
    • Overview of self-identification process
    • Strategies for payment: How are consortia dividing up fees between participants?

  6. Q&A

  7. TSCA new chemical programme

    • Changes under the LCSA
    • Their Impact on the Chemical Industry
    • Practical Considerations and Recommendations

  8. TSCA new chemical programme statistics and pre-manufacture notice (PMN) status

    • Programme statistics: update on PMN 'backlog' and EPA new chemical review efforts
    • A reflection on PMN submissions since the new higher fees took effect

  9. Q&A

  10. Chemical Watch platform and service demonstration

  11. Break

  12. Session two: Risk management and evaluation

  13. A reflection on recent risk evaluations: NGO perspective

    Is the EPA risk evaluation process effectively protecting the public?

    • The impact of the SACC peer review process
    • Gaps in the EPA evaluations
    • Important policy and legal issues

  14. Preview of emerging issues on the next 20 risk evaluations: Lessons learned from the first 10

    • Should we expect the EPA to issue test orders and make other efforts to fill data gaps? 
    • What role are industry consortia playing in this process?

  15. Q&A

  16. Session three: Confidential business information (CBI) under TSCA, enforcement and litigation

  17. CBI substantiation overview

    • Issues that could cause the EPA to drop a chemical identity confidentiality claim and what recourse companies have to stop this
    • An insight into CBI’s upfront substantiation requirements

  18. Enforcement and litigation issues including enforcement during the Covid-19 pandemic

  19. Q&A

  20. Break

  21. Session four: Stakeholder perspectives and outlooks

  22. Covid 19 – the impact of the coronavirus on TSCA

  23. Reflections on four years of implementing the Lautenberg Amendments: a former EPA insider’s perspective and advice

  24. Stakeholder panel: A look to the future

  25. Q&A and conference wrap-up

    Chemical Watch